Subclassifications Of Assets, Liabilities And Equities [Abstract]

Ascelia Pharma - Filing #689421

Concept	As at 2022-12-31	As at 2021-12-31	As at 2020-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	163,000 SEK	238,000 SEK	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	57 074 SEK	57 063 SEK	—
Trade and other current receivables [abstract]
Current prepayments and current accrued income other than current contract assets [abstract]
Current prepayments [abstract]
Current advances to suppliers	5 359 SEK	6 175 SEK	—
Other current receivables	1 745 SEK	1 165 SEK	—
Current prepayments and current accrued income including current contract assets [abstract]
Current prepayments and current accrued income including current contract assets	1 426 SEK	1 277 SEK	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	149 555 SEK	261 599 SEK	184 686 SEK
Trade and other current payables [abstract]
Current trade payables	15 881 SEK	6 147 SEK	—
Current accruals and current deferred income including current contract liabilities [abstract]
Current accruals and current deferred income including current contract liabilities	19 657 SEK	16 343 SEK	—
Miscellaneous current liabilities [abstract]
Other current liabilities	1 688 SEK	1 509 SEK	—
Issued capital [abstract]
Issued capital	34 871 SEK	34 576 SEK	—
Retained earnings [abstract]
Retained earnings	533 478 SEK	405 827 SEK	—
Accumulated other comprehensive income [abstract]
Reserve of exchange differences on translation	718,000 SEK	254,000 SEK	—
Miscellaneous equity [abstract]
Additional paid-in capital	678 747 SEK	678 831 SEK	—
Net assets (liabilities) [abstract]
Assets	218 569 SEK	333 493 SEK	—
Liabilities	37 711 SEK	25 659 SEK	—
Net current assets (liabilities) [abstract]
Current assets	160 869 SEK	274 611 SEK	—
Current liabilities	37 518 SEK	25 106 SEK	—
Assets less current liabilities [abstract]